Literature DB >> 26374280

COPD and its comorbidities: Impact, measurement and mechanisms.

Netsanet A Negewo1, Peter G Gibson1,2, Vanessa M McDonald1,3,2.   

Abstract

Chronic obstructive pulmonary disease (COPD) frequently coexists with other conditions often known as comorbidities. The prevalence of most of the common comorbid conditions that accompany COPD has been widely reported. It is also recognized that comorbidities have significant health and economic consequences. Nevertheless, there is scant research examining how comorbidities should be assessed and managed in the context of COPD. Also, the underlying mechanisms linking COPD with its comorbidities are still not fully understood. Owing to these knowledge gaps, current disease-specific approaches provide clinicians with little guidance in terms of managing comorbid conditions in the clinical care of multi-diseased COPD patients. This review discusses the concepts of comorbidity and multi-morbidity in COPD in relation to the overall clinical outcome of COPD management. It also summarizes some of the currently available clinical scores used to measure comorbid conditions and their prognostic abilities. Furthermore, recent developments in the proposed mechanisms linking COPD with its comorbidities are discussed.
© 2015 Asian Pacific Society of Respirology.

Entities:  

Keywords:  chronic obstructive pulmonary disease; comorbidity; multi-morbidity; prognostic index

Mesh:

Year:  2015        PMID: 26374280     DOI: 10.1111/resp.12642

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  60 in total

1.  Efficacy of tiotropium bromide combined with different doses of fluticasone plus salmeterol DPI in the treatment of stable COPD.

Authors:  Xiao Ma; Jingjing Xu; Jun Yang
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

2.  Impact of renal dysfunction on in-hospital mortality of patients with severe chronic obstructive pulmonary disease: a single-center Italian study.

Authors:  Fabio Fabbian; Alfredo De Giorgi; Fabio Manfredini; Nicola Lamberti; Silvia Forcellini; Alda Storari; Massimo Gallerani; Gaetano Caramori; Roberto Manfredini
Journal:  Int Urol Nephrol       Date:  2016-03-28       Impact factor: 2.370

3.  Impact of chronic kidney disease among Korean adults with chronic obstructive pulmonary disease.

Authors:  Min Young Kim; Sungmin Boo; Mijung Yoo; Jonghyun Lee; Na Ree Kang
Journal:  Int Urol Nephrol       Date:  2017-04-06       Impact factor: 2.370

4.  Effect of high quality nursing and respiratory training on pulmonary function and quality of life in patients with chronic obstructive pulmonary disease.

Authors:  Qiubo Zhang; Sufang Liu; Gang Gu; Lingbo Wu; Zimeng Zhu; Yuhong Mao; Fen Zhang
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

5.  Predicting Hospitalization Due to COPD Exacerbations in Swedish Primary Care Patients Using Machine Learning - Based on the ARCTIC Study.

Authors:  Björn Ställberg; Karin Lisspers; Kjell Larsson; Christer Janson; Mario Müller; Mateusz Łuczko; Bine Kjøller Bjerregaard; Gerald Bacher; Björn Holzhauer; Pankaj Goyal; Gunnar Johansson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-03-16

Review 6.  Harnessing the ECM Microenvironment to Ameliorate Mesenchymal Stromal Cell-Based Therapy in Chronic Lung Diseases.

Authors:  Linda Elowsson Rendin; Anna Löfdahl; Måns Kadefors; Zackarias Söderlund; Emil Tykesson; Sara Rolandsson Enes; Jenny Wigén; Gunilla Westergren-Thorsson
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

7.  miR-937 serves as an inflammatory inhibitor in cigarette smoke extract-induced human bronchial epithelial cells by targeting IL1B and regulating TNF-α/IL-17 signaling pathway.

Authors:  Teng Liu
Journal:  Tob Induc Dis       Date:  2021-06-25       Impact factor: 2.600

8.  Correlation in gene expression between the aggravation of chronic obstructive pulmonary disease and the occurrence of complications.

Authors:  Yuchen Cai; Runhan Liu; Xinhe Lu; Qiming Zhang; Xinwei Wang; Huijing Lian; Haohua Wang
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

Review 9.  Emerging Biological Functions of IL-17A: A New Target in Chronic Obstructive Pulmonary Disease?

Authors:  Meiling Liu; Kang Wu; Jinduan Lin; Qingqiang Xie; Yuan Liu; Yin Huang; Jun Zeng; Zhaogang Yang; Yifan Wang; Shiyan Dong; Weiye Deng; Mingming Yang; Song Wu; Wen Jiang; Xuefeng Li
Journal:  Front Pharmacol       Date:  2021-07-02       Impact factor: 5.810

10.  Distribution of COPD Comorbidities and Creation of Acute Exacerbation Risk Score: Results from SCICP.

Authors:  Haiyan Ge; Xuanqi Liu; Wenchao Gu; Xiumin Feng; Fengying Zhang; Fengfeng Han; Yechang Qian; Xiaoyan Jin; Beilan Gao; Li Yu; Hong Bao; Min Zhou; Shengqing Li; Zhijun Jie; Jian Wang; Zhihong Chen; Jingqing Hang; Jingxi Zhang; Huili Zhu
Journal:  J Inflamm Res       Date:  2021-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.